These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18215088)

  • 21. Perspectives on DNA vaccines. Targeting staphylococcal adhesins to prevent implant infections.
    Arciola CR; Speziale P; Montanaro L
    Int J Artif Organs; 2009 Sep; 32(9):635-41. PubMed ID: 19882551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects".
    Jansen KU; Girgenti DQ; Scully IL; Anderson AS
    Vaccine; 2013 Jun; 31(25):2723-30. PubMed ID: 23624095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; García P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel linear B-cell epitope as a vaccine candidate in the N2N3 subdomain of Staphylococcus aureus fibronectin-binding protein A.
    Ma J; Wei Y; Zhang L; Wang X; Yao D; Liu D; Liu W; Yu S; Yu Y; Wu Z; Yu L; Zhu Z; Cui Y
    J Med Microbiol; 2018 Mar; 67(3):423-431. PubMed ID: 29458526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
    PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoinformatics analysis and in silico designing of a novel multi-epitope peptide vaccine against Staphylococcus aureus.
    Hajighahramani N; Nezafat N; Eslami M; Negahdaripour M; Rahmatabadi SS; Ghasemi Y
    Infect Genet Evol; 2017 Mar; 48():83-94. PubMed ID: 27989662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections.
    Casolini F; Visai L; Joh D; Conaldi PG; Toniolo A; Höök M; Speziale P
    Infect Immun; 1998 Nov; 66(11):5433-42. PubMed ID: 9784554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
    Fattom A; Matalon A; Buerkert J; Taylor K; Damaso S; Boutriau D
    Hum Vaccin Immunother; 2015; 11(3):632-41. PubMed ID: 25483694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immunological parameters in rabbits inoculated with Staphylococcus aureus in view of specific and non-specific stimulation.
    Giedrys-Galant S; Podkowińska I; Hałasa J; Bohatyrewicz R; Daszko J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):583-7. PubMed ID: 749812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antistaphylococcal vaccines and immunoglobulins: current status and future prospects.
    Deresinski S
    Drugs; 2006; 66(14):1797-806. PubMed ID: 17040111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.
    Daly SM; Joyner JA; Triplett KD; Elmore BO; Pokhrel S; Frietze KM; Peabody DS; Chackerian B; Hall PR
    Sci Rep; 2017 Apr; 7(1):637. PubMed ID: 28377579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.
    Nissen M; Marshall H; Richmond P; Shakib S; Jiang Q; Cooper D; Rill D; Baber J; Eiden J; Gruber W; Jansen KU; Emini EA; Anderson AS; Zito ET; Girgenti D
    Vaccine; 2015 Apr; 33(15):1846-54. PubMed ID: 25707693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.